Performance status and deaths among children registered in Kuwait National Primary ImmunoDeficiency Disorders Registry
Affiliations
Affiliations
- Department of Pediatrics, Al-Sabah Hospital, Kuwait. wemh@hotmail.com
01 June 2010
Abstract
Children with primary immunodeficiency disorders (PIDD) have an increased risk of suffering from physical, social, and psychological problems. The aim of this study was to evaluate the performance status and mortality of children with PIDD in Kuwait and to determine the variables and co-morbidities that may affect their performance and risk of death. The data for the children were obtained from Kuwait National Primary Immunodeficiency Disorders Registry describes the patients' characteristics, comorbidities and their treatment regimens. Each patient was scored using the Lansky Play Performance Scale (LPPS), and we evaluated the number of deaths among the children and the effects of different variables on their LPPS scores and mortality. We examined 98 pediatric patients with a mean delay in diagnosis of 21.2 months. Antimicrobial prophylaxis was administered to 57.2% of the patients, whereas intravenous immunoglobulin (IVIG) therapy was used in 44%. Eight patients underwent bone marrow transplants. The mean LPPS score for all the patients was 65.5, and there was a significant disparity in the mean LPPS scores across PIDD categories. Twenty-one patients died. The variables that were found to have a significant effect on both the LPPS score and the risk of death were an age of onset of less than 6 months, a history of CMV infection, parental consanguinity, the use of antimicrobial prophylaxis and IVIG therapy. In conclusion, patients with PIDD have a poor performance status and a high rate of mortality. Early diagnosis and aggressive therapeutic interventions directed at patients with early onset of symptoms and CMV infections can help improve the quality of life of patients with PIDD.
Similar articles
Al-Herz W, Naguib KK, Notarangelo LD, Geha RS, Alwadaani A.Int Arch Allergy Immunol. 2011;154(1):76-80. doi: 10.1159/000319212. Epub 2010 Jul 27.PMID: 20664281
Al-Herz W, Notarangelo LD, Sadek A, Buckley R; USIDNET Consortium.Clin Immunol. 2015 Dec;161(2):170-3. doi: 10.1016/j.clim.2015.07.013. Epub 2015 Aug 3.PMID: 26248333 Free PMC article.
Al-Herz W.J Clin Immunol. 2008 Mar;28(2):186-93. doi: 10.1007/s10875-007-9144-5. Epub 2007 Nov 16.PMID: 18008151 Free PMC article.
Kobrynski LJ, Mayer L.Clin Immunol. 2011 Jun;139(3):238-48. doi: 10.1016/j.clim.2011.01.008. Epub 2011 Jan 26.PMID: 21489888 Review.
[Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].
Pac M.Pol Merkur Lekarski. 2011 Jun;30(180):413-6.PMID: 21751550 Review. Polish.
Cited by
Al-Saud B, AlRumayyan N, Alfattani A, Awwad SA, Al Saud D, Mohammed R, Albuhairi S, Elshorbagi S, Balhareth SS, Al-Dhekri H, Arnaout R, De Vol EB, Al-Mousa H.J Clin Immunol. 2023 Aug;43(6):1360-1366. doi: 10.1007/s10875-023-01507-6. Epub 2023 May 5.PMID: 37145392 Free PMC article.
Styczynski J.Infect Dis Ther. 2018 Mar;7(1):1-16. doi: 10.1007/s40121-017-0180-z. Epub 2017 Dec 4.PMID: 29204910 Free PMC article. Review.
Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital.
Al-Tamemi S, Naseem SU, Al-Siyabi N, El-Nour I, Al-Rawas A, Dennison D.J Clin Immunol. 2016 Nov;36(8):785-792. doi: 10.1007/s10875-016-0337-7. Epub 2016 Oct 3.PMID: 27699572
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.
Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, Erichsen HC, Forbes LR, Gu S, Yuan B, Jhangiani SN, Muzny DM, Rødningen OK, Sheng Y, Nicholas SK, Noroski LM, Seeborg FO, Davis CM, Canter DL, Mace EM, Vece TJ, Allen CE, Abhyankar HA, Boone PM, Beck CR, Wiszniewski W, Fevang B, Aukrust P, Tjønnfjord GE, Gedde-Dahl T, Hjorth-Hansen H, Dybedal I, Nordøy I, Jørgensen SF, Abrahamsen TG, Øverland T, Bechensteen AG, Skogen V, Osnes LTN, Kulseth MA, Prescott TE, Rustad CF, Heimdal KR, Belmont JW, Rider NL, Chinen J, Cao TN, Smith EA, Caldirola MS, Bezrodnik L, Lugo Reyes SO, Espinosa Rosales FJ, Guerrero-Cursaru ND, Pedroza LA, Poli CM, Franco JL, Trujillo Vargas CM, Aldave Becerra JC, Wright N, Issekutz TB, Issekutz AC, Abbott J, Caldwell JW, Bayer DK, Chan AY, Aiuti A, Cancrini C, Holmberg E, West C, Burstedt M, Karaca E, Yesil G, Artac H, Bayram Y, Atik MM, Eldomery MK, Ehlayel MS, Jolles S, Flatø B, Bertuch AA, Hanson IC, Zhang VW, Wong LJ, Hu J, Walkiewicz M, Yang Y, Eng CM, Boerwinkle E, Gibbs RA, Shearer WT, Lyle R, Orange JS, Lupski JR.J Allergy Clin Immunol. 2017 Jan;139(1):232-245. doi: 10.1016/j.jaci.2016.05.042. Epub 2016 Jul 16.PMID: 27577878 Free PMC article.
Bienvenu B, Cozon G, Hoarau C, Pasquet M, Cherin P, Clerson P, Hachulla E, Crave JC, Delain JC, Jaussaud R.Orphanet J Rare Dis. 2016 Jun 22;11(1):83. doi: 10.1186/s13023-016-0452-9.PMID: 27334100 Free PMC article.